000 | a | ||
---|---|---|---|
999 |
_c15750 _d15750 |
||
003 | OSt | ||
005 | 20220730102438.0 | ||
008 | 211224b xxu||||| |||| 00| 0 eng d | ||
040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
100 |
_915075 _aParavastu, Venkata Kamala Kumari |
||
245 | _aApplication of Box-Behnken Design for Formulation Parameters of Eslicarbazepine Tablets | ||
250 | _aVol.83(3), May-June | ||
260 |
_aMumbai _bIndian Journal of Pharmaceutical Science _c2021 |
||
300 | _a575-583p. | ||
520 | _aCurrent research has been done to develop statistically and optimized immediate release tablets for eslicarbazepine. Nineteen formulations of eslicarbazepine acetate immediate release tablets are prepared by wet granulation. The three-dimensional Box-Behnken design at three levels (33) was developed to study how selected independent variables affect dependent responses. After the initial test, three independent items were selected as follows; polyvinylpyrrolidone (A), tapioca starch (B) and galbanum gum (C). Responses to measure were the time of disintegration (Y1) and in vitro drug release at 45 min (Y2). In accordance with the independent variables, three different levels were established as the lowest, highest and middle variables tested. The predicted formula formulated with the Box-Behnken statistical design consisted of polyvinylpyrrolidone, tapioca starch and galbanum gum at the optimum levels of 2.49, 2.77 and 3 respectively. | ||
650 | 0 |
_94639 _aPHARMACEUTICS |
|
700 |
_915076 _a YARRAGUNTLA, S. R. |
||
773 | 0 |
_dNew Delhi _tIndian journal of pharmaceutical sciences |
|
856 |
_uhttps://www.ijpsonline.com/articles/application-of-boxbehnken-design-for-formulation-parameters-of-eslicarbazepine-tablets.pdf _yClick here |
||
942 |
_2ddc _cAR |